Home/Filings/4/0001562180-23-004642
4//SEC Filing

GOTTSCHALK ADRIAN 4

Accession 0001562180-23-004642

CIK 0001822462other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 9:22 PM ET

Size

7.4 KB

Accession

0001562180-23-004642

Insider Transaction Report

Form 4
Period: 2023-05-26
GOTTSCHALK ADRIAN
DirectorChief Executive Officer
Transactions
  • Gift

    Common Stock

    2023-05-26300,000448,704 total(indirect: See Footnote)
  • Gift

    Common Stock

    2023-05-26+300,000448,704 total(indirect: See Footnote)
Footnotes (2)
  • [F1]On May 26, 2023, 300,000 shares of the Issuer's Common Stock were transferred from the Adrian H. Gottschalk Living Trust dated September 8, 2009 to the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023. This was a bona fide gift with no payment in consideration.
  • [F2]Consists of 300,000 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary, 110,690 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 38,014 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.

Issuer

Foghorn Therapeutics Inc.

CIK 0001822462

Entity typeother

Related Parties

1
  • filerCIK 0001828724

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 9:22 PM ET
Size
7.4 KB